Investing Ideas
/
Australian Pharmaceuticals & Biotech High Insider Buying

Australian Pharmaceuticals & Biotech High Insider Buying

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

19 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
MSB Mesoblast	AU$2.96	-4.5%	938.6%	AU$3.4b	AU$1.86	PS354.9x	E53.7%	n/a
OCC Orthocell	AU$1.42	4.8%	255.0%	AU$339.8m	n/a	PS63.9x	n/a	n/a
TRJ Trajan Group Holdings	AU$1.08	-4.4%	-8.9%	AU$164.5m	AU$1.45	PS1.1x	E98.8%	n/a
PAR Paradigm Biopharmaceuticals	AU$0.47	25.3%	9.3%	AU$164.2m	AU$0.85	PB6.9x	E-13.2%	n/a
EZZ EZZ Life Science Holdings	AU$2.87	-6.5%	378.3%	AU$132.5m	AU$5.45	PE19x	E17.9%	1.0%
VFY Vitrafy Life Sciences	AU$1.71	0.6%	n/a	AU$109.2m	AU$2.43	PS2937.7x	E45.7%	n/a
NUZ Neurizon Therapeutics	AU$0.17	0%	41.7%	AU$83.6m	AU$0.56	PS99.3x	S58.2%	n/a
ACW Actinogen Medical	AU$0.026	4.0%	23.8%	AU$79.9m	n/a	PS8x	E-22.1%	n/a
SPL Starpharma Holdings	AU$0.11	0%	-29.0%	AU$46.0m	n/a	PS4.7x	n/a	n/a
LGP Little Green Pharma	AU$0.12	-4.0%	-17.2%	AU$36.3m	n/a	PS1.3x	n/a	n/a
ATX Amplia Therapeutics	AU$0.086	-3.4%	8.9%	AU$29.8m	AU$0.24	PS8.7x	n/a	n/a
OSL OncoSil Medical	AU$0.005	-16.7%	-37.5%	AU$22.5m	n/a	PS14.4x	n/a	n/a
CAN Cann Group	AU$0.039	0%	-58.9%	AU$20.9m	n/a	PS1.1x	n/a	n/a
AGH Althea Group Holdings	AU$0.034	0%	-5.6%	AU$17.3m	n/a	PS0.6x	n/a	n/a
RGT Argent BioPharma	AU$0.24	44.1%	-50.0%	AU$13.3m	n/a	PS14.9x	n/a	n/a
RNO Rhinomed	AU$0.04	-7.0%	-55.6%	AU$11.5m	n/a	PS1.4x	n/a	n/a
EOF Ecofibre	AU$0.032	6.7%	-72.2%	AU$11.7m	n/a	PS0.4x	n/a	n/a
PER Percheron Therapeutics	AU$0.008	14.3%	-86.2%	AU$8.5m	AU$0.09	PS2.9x	E24.7%	n/a
CHM Chimeric Therapeutics	AU$0.006	-14.3%	-82.4%	AU$6.0m	n/a	PS0.8x	n/a	n/a

Page 1 of 1